Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors as a first-line treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase: A mixed-treatment comparison

Published:2015-10-28 Issue:6 Volume:138 Page:1545-1553
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Firwana Belal¹²,Sonbol Mohamad Bassam³,Diab Maria⁴,Raza Shahzad²⁵,Hasan Rim⁶,Yousef Ibrahim⁷,Zarzour Ahmad⁸,Garipalli Archana²,Doll Donald²,Murad M. Hassan⁹,Al-Kali Aref¹⁰

Affiliation:

1. University of Arkansas for Medical Sciences/Winthrop Rockefeller Cancer Institute; Little Rock AR

2. Ellis Fischel Cancer Center, University of Missouri; Columbia MO

3. Department of Medicine; Georgia Regents University; Augusta GA

4. Department of Medicine; Wayne State University; Detroit MI

5. Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center; New York NY

6. Division of Endocrinology and Metabolism, University of Arkansas for Medical Sciences; Little Rock AR

7. Department of Medicine; Indiana University; Indianapolis IN

8. Cleveland Clinic; Cleveland OH

9. Division of Preventive Medicine; Mayo Clinic; Rochester MN

10. Division of Hematology; Mayo Clinic; Rochester MN

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Treatments for chronic myeloid leukemia: a qualitative systematic review;Ferdinand;J Blood Med,2012

3. A critical review of trials of first-line BCR-ABL inhibitor treatment in patients with newly diagnosed chronic myeloid leukemia in chronic phase;Jabbour;Clin Lymphoma Myeloma Leukemia,2013

4. Bcr-Abl tyrosine kinase inhibitors-current status;Mughal;Infect Agents Cancer,2013

5. Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders;Bonifazi;Blood,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: A study using the French health insurance database;Fundamental & Clinical Pharmacology;2023-04-24

2. Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France;Frontiers in Oncology;2021-09-30

3. First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis;Blood Advances;2020-06-19

4. Systematic Review and Meta-Analysis of New-Generation Tyrosine Kinase Inhibitors versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia;Acta Haematologica;2019-09-12

5. Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology;Medicina;2019-07-28